Romainville, France

René Alexandre Galien

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Innovations by René Alexandre Galien

Introduction

René Alexandre Galien is a notable inventor based in Romainville, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory disorders. With a total of 2 patents, his work has the potential to impact various medical conditions.

Latest Patents

Galien's latest patents focus on compounds and pharmaceutical compositions for the treatment of inflammatory disorders. The inventions disclose compounds according to specific formulas, which are designed to address a range of diseases. These include allergic diseases, inflammatory diseases, metabolic diseases, autoinflammatory diseases, autoimmune diseases, proliferative diseases, transplantation rejection, and conditions associated with cartilage turnover and hypersecretion of certain cytokines.

Career Highlights

René Alexandre Galien is associated with Galapagos NV, a company known for its innovative approaches in drug discovery and development. His work at Galapagos has allowed him to explore and develop new therapeutic options for patients suffering from complex inflammatory conditions.

Collaborations

Throughout his career, Galien has collaborated with notable colleagues, including Steven Emiel Van Der Plas and Oscar Mammoliti. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

René Alexandre Galien's contributions to pharmaceutical innovations demonstrate his commitment to improving treatment options for inflammatory disorders. His patents reflect a deep understanding of complex medical challenges and a dedication to finding effective solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…